Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 Apr 10;1(6014):867–870. doi: 10.1136/bmj.1.6014.867

Bronchial reactivity to histamine before and after sodium cromoglycate in bronchial asthma.

B Kang, R G Townley, C K Lee, B Miller Kolotkin
PMCID: PMC1639585  PMID: 816411

Abstract

Out of 19 patients with extrinsic bronchial asthma challenged with 123 mug histamine acid phosphate by intravenous infusion only 13 responded with a fall in FEV1 of over 10% (mean 16%). Seventeen of these patients were given histamine 2 mg/ml by aerosol, and all responded with a mean decrease in FEV1 of 37.8%. When challenged with allergen extract by aerosol the mean decrease in FEV1 was 37.5%. After 40 mg sodium cromoglycate 15 of the 17 patients showed significant protection against allergen challenge with a mean decrease in FEV1 of only 23.6%. Inhalation of 40 mg sodium cromoglycate, however, failed to protect against histamine given by either the intravenous or aerosol route. Histamine given intravenously to asthmatic patients produces less of a bronchial response than when given by aerosol, even though the intravenous route produces many more systemic symptoms, such as flushing and throbbing headache. The protection of sodium cromoglycate against an allergen inhalation challenge is not due to histamine antagonsim.

Full text

PDF
867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox J. S. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature. 1967 Dec 30;216(5122):1328–1329. doi: 10.1038/2161328a0. [DOI] [PubMed] [Google Scholar]
  2. DeKock M. A., Nadel J. A., Zwi S., Colebatch H. J., Olsen C. R. New method for perfusing bronchial arteries: histamine bronchoconstriction and apnea. J Appl Physiol. 1966 Jan;21(1):185–194. doi: 10.1152/jappl.1966.21.1.185. [DOI] [PubMed] [Google Scholar]
  3. Kerr J. W., Govindaraj M., Patel K. R. Effect of alpha-receptor blocking drugs and disodium cromoglyate on histamine hypersensitivity in bronchial asthma. Br Med J. 1970 Apr 18;2(5702):139–141. doi: 10.1136/bmj.2.5702.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kolotkin B. M., Lee C. K., Townley R. G. Duration and specificity of sodium cromolyn on allergen inhalation challenges in asthmatics. J Allergy Clin Immunol. 1974 May;53(5):288–297. doi: 10.1016/0091-6749(74)90108-0. [DOI] [PubMed] [Google Scholar]
  5. Pegelow K. O. Bronchial reactivity to inhaled histamine in asthmatic patients, before and after administration of atropine, phentolamine or disodium cromoglycate. Acta Allergol. 1974 Oct;29(5):365–384. doi: 10.1111/j.1398-9995.1974.tb01472.x. [DOI] [PubMed] [Google Scholar]
  6. Pepys J., Hargreave F. E., Chan M., McCarthy D. S. Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet. 1968 Jul 20;2(7560):134–137. doi: 10.1016/s0140-6736(68)90419-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES